Skip to content

The pharmacological material basis and clinical research of Jiajianjinfeicaosan in the treatment of cough variant asthma based on the "Fu Feng" theory

The pharmacological material basis and clinical research of Jiajianjinfeicaosan in the treatment of cough variant asthma based on the "Fu Feng" theory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000199
Enrollment
Unknown
Registered
2026-01-28
Start date
2025-02-16
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough variant asthma

Interventions

Control group:Take the placebo of Jiajianjinfeicaosan Granules
Experimental Group: Take the Jiajianjinfeicaosan Granules

Sponsors

Chongqing Hospital of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine(Beibei District Hospital of Traditional Chinese Medicine Chongqing City)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Conform to the diagnostic criteria of CVA; 2) In traditional Chinese medicine the disease is diagnosed as wind-cough and the syndrome is determined to be wind-pathogen invading the lung syndrome. 3) Aged between 16 and 80; 4) Those who voluntarily accept observation and treatment;.

Exclusion criteria

Exclusion criteria: 1)Those diagnosed with wind-induced cough but not belonging to the syndrome of wind pathogen invading the lung; 2) Pregnant and lactating women; 3) Patients with unconsciousness dementia and various mental illnesses; 4) Those with cardiac insufficiency and hemodynamic instability; 5) Patients with a history of chronic respiratory diseases combined with active pulmonary tuberculosis obliterative bronchiolitis diffuse panbronchiolitis pulmonary embolism pneumothorax and pleural effusion; 6) People with severe liver and kidney diseases and those using other drugs that act on the liver and kidneys; 7) Those who are currently participating in clinical trials of other drugs and are known to be allergic to therapeutic drugs; 8) Personnel who are currently using other traditional Chinese medicines Chinese patent medicines and health products.

Design outcomes

Primary

MeasureTime frame
Pulmonary Function Test;

Secondary

MeasureTime frame
TCM Syndrome Points;cough evaluation test;

Countries

China

Contacts

Public ContactLi Chang

Employment relationship

1398867572@qq.com13628319840

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026